JiscMail Logo
Email discussion lists for the UK Education and Research communities

Help for ACAD-AE-MED Archives


ACAD-AE-MED Archives

ACAD-AE-MED Archives


ACAD-AE-MED@JISCMAIL.AC.UK


View:

Message:

[

First

|

Previous

|

Next

|

Last

]

By Topic:

[

First

|

Previous

|

Next

|

Last

]

By Author:

[

First

|

Previous

|

Next

|

Last

]

Font:

Proportional Font

LISTSERV Archives

LISTSERV Archives

ACAD-AE-MED Home

ACAD-AE-MED Home

ACAD-AE-MED  April 2001

ACAD-AE-MED April 2001

Options

Subscribe or Unsubscribe

Subscribe or Unsubscribe

Log In

Log In

Get Password

Get Password

Subject:

Naloxone

From:

john ryan <[log in to unmask]>

Reply-To:

The list will be of relevance to all trainees including undergraduates and <[log in to unmask]>

Date:

Sun, 8 Apr 2001 10:54:16 +0100

Content-Type:

text/plain

Parts/Attachments:

Parts/Attachments

text/plain (208 lines)

The problem with opiate reversal is that it is often performed by junior
staff whose aim is to get the patient 'back to normal'.  However most
opiate overdoses occur concommitantly with alcohol and benzodiazepines so
even when the patient wakes up they are often still spaced from other
substances.  The aim should be to return the patient to normal spontaneous
ventilation with good tidal flows and not just a decent repsiratory rate.
 This can be achieved with small doses of naloxone or infusion.

We are all concerned in case the agitated chap who we wake up will go off
and collapse later when the naloxone wears off.  There is little evidence
that this in fact happens.  Indeed one study showed that none of 317
patients who were reversed by paramedics and who refused further treatement
were found dead within 12 hours of administration of naloxone [1].

Allowing patients to wake up slowly means you have the opportunity to
ensure they are informed about risk modification and also inform them about
the availability of local services.  If they wake up after a few hours and
want to leave then it is less likely that you are dealing with a methadone
overdose. You are also less likely to encounter acute withdrawl and the
risks that perhaps vomiting can bring on top of  co-ingestion of alcohol.
 But remember that scary paper from 1996 BMJ lesson of the week of the chap
who was found dead on the ward after release from ITU when naloxone
infusion was stopped ?  [2]

I think it was Greg Henry who said 'I never wake up anyone I dont like' !

John Ryan


[1]  Prehosp Emerg Care 1999 Jul-Sep;3(3):183-6

Are heroin overdose deaths related to patient release after prehospital
treatment
with naloxone?

Vilke GM, Buchanan J, Dunford JV, Chan TC.

Department of Emergency Medicine, University of California, San Diego
Medical
Center, 92103, USA. [log in to unmask]

OBJECTIVE: Naloxone is frequently used by prehospital care providers to
treat
suspected heroin and opioid overdoses. The authors' EMS system has operated
a policy of allowing these patients, once successfully treated, to sign out
against medical advice (AMA) in the field. This study was performed to
evaluate
the safety of this practice. METHODS: The authors retrospectively reviewed
all
1996 San Diego County Medical Examiner's (ME's) cases in which opioid
overdoses
contributed to the cause of death. The records of all patients who were
found
dead in public or private residences or died in emergency departments of
reasons
other than natural causes or progression of disease, are forwarded to the
ME
office. ME cases associated with opiate use as a cause of death were
cross-compared
with all patients who received naloxone by field paramedics and then
refused
transport. The charts were reviewed by dates, times, age, sex, location,
and,
when available, ethnicity. RESULTS: There were 117 ME cases of opiate
overdose
deaths and 317 prehospital patients who received naloxone and refused
further
treatment. When compared by age, time, date, sex, location, and ethnicity,
there
was no case in which a patient was treated by paramedics with naloxone
within
12 hours of being found dead of an opiate overdose. CONCLUSIONS: Giving
naloxone
to heroin overdoses in the field and then allowing the patients to sign out
AMA resulted in no death in the one-year period studied. This study did not
evaluate for return visits by paramedics nor whether patients were later
taken
to hospitals by private vehicles.

[2]   BMJ 1996;313:481-482 (24 August)

http://bmj.com/cgi/content/full/313/7055/481?view=full&pmid=8776322

Education and debate
Lesson of the Week: Fatal methadone overdose
T J Hendra, consultant physician,a S P Gerrish, consultant anaesthetist,a A
R W Forrest, consultant chemical pathologist a
a Directorate of Medicine, Intensive Care Unit and Department of Clinical
Chemistry,
Royal Hallamshire Hospital, Sheffield S10 2JF

Correspondence to: Dr T J Hendra, Department of Geriatric Medicine, Royal
Hallamshire
Hospital, Sheffield S10 2JF.

Methadone is a synthetic opioid with potent analgesic effects often used
for
the detoxification or maintenance of an opiate addict. It differs from
morphine
in that it has an exceptionally prolonged duration of action with a half
life
averaging 25 hours, although durations of up to 52 hours have been reported
during long term maintenance treatment.1 The variation in metabolism may be
responsible for the irregular and unpredictable clinical course of patients
who have taken overdoses of this agent.




 Methadone
 overdose can
 follow an
 unpredictable
 course in non-
 tolerant patients,
 who are at risk of
 sudden death



Case report

A 22 year old man presented to the accident and emergency department at
1400
hours having taken an overdose of 420 mg of methadone three hours earlier;
he
had obtained the drug illicitly. He was a known drug misuser who had
epilepsy,
treated with sodium valproate. He had been treated before for depression
with
amitriptyline and fluoxetine. A heavy cigarette smoker with a high alcohol
intake,
he had taken four overdoses within the past two months.

On arrival he was drowsy and refused to submit to regular nursing
observations.
On leaving the hospital, he collapsed on the pavement while smoking a
cigarette.
After being brought back into the department, unconscious and unresponsive
to
pain, he was given three 0.4 mg boluses of intravenous naloxone and 0.4 mg
flumazenil,
with a prompt improvement in his level of consciousness. He was transferred
to the admissions ward, where he cooperated poorly with monitoring by the
nursing
staff and hindered the use of a pulse oximeter by frequently getting out of
bed and wandering out of the ward. At 1830 hours he had an episode of
altered
consciousness and responded to 0.4 mg naloxone within two minutes. At 2130
hours
a naloxone infusion of 0.3 mg/hour was started following another episode of
unconsciousness associated with an oximeter oxygen saturation of 22%.

He was transferred to the intensive care unit, where he remained
haemodynamically
stable but had a fluctuating level of consciousness, varying from wide
awake
to rousable on request. The naloxone infusion of 0.3 mg/hour was continued,
and a bolus injection of 0.2 mg given at 2345 hours greatly improved his
level
of consciousness. Blood was taken for toxicological analysis and oxygen
administered
via a face mask.

The following morning the naloxone infusion was temporarily stopped to
assess
whether it was still required and he got up to smoke a cigarette under
nursing
supervision. After he became sleepy, but was still rousable and able to
communicate,
the naloxone infusion was restarted at a rate of 0.2 mg/hour with good
effect.
He was seen by the on call psychiatric team and a decision was made to
discharge
him back to the general medical ward if stable. Before leaving the
intensive
care unit at 1800 hours the serum toxicology results were reported as
methadone
353 ?g/l, temazepam <50 ?g/l, desipramine <50 ?g/l, diazepam 813 ?g/l, and
nordiazepam
990 ?g/l. The therapeutic ranges given were up to 250 ?g/l for diazepam and
up to 1000 ?g/l for methadone. The laboratory also commented that while
serum
methadone concentrations of up to 1000 ?g/l were found in patients
receiving
methadone maintenance treatment, death following overdose might be
associated
with a concentration as low as 200 ?g/l in blood. He was transferred awake
and
alert to a general medical ward with instructions for the naloxone infusion
to finish later that evening.

On the medical ward he was mobile and talking to the nursing staff until
0200
hours, when he had a cup of hot chocolate before retiring to bed. He was
not
being monitored by an oximeter at this time. The naloxone infusion was slow
to complete, eventually finishing at 0330. He was observed to be sleeping
and
breathing satisfactorily at 0400 but was found dead in bed at 0655.

At necropsy there were no clinically relevant physical findings: his
methadone
concentration was 822 ?g/l in femoral blood and 7 ?g/l in stomach contents.
Diazepam and nordiazepam blood concentrations were 103 ?g/l and 165 ?g/l,
respectively.
The pathologist's opinion of the cause of death was methadone overdose.

Top of Message | Previous Page | Permalink

JiscMail Tools


RSS Feeds and Sharing


Advanced Options


Archives

May 2024
April 2024
March 2024
February 2024
January 2024
December 2023
November 2023
October 2023
September 2023
August 2023
July 2023
June 2023
May 2023
April 2023
March 2023
February 2023
January 2023
December 2022
November 2022
September 2022
July 2022
February 2022
January 2022
October 2021
September 2021
August 2021
June 2021
May 2021
April 2021
March 2021
April 2020
March 2020
February 2020
September 2019
March 2019
April 2018
January 2018
November 2017
May 2017
March 2017
November 2016
February 2016
January 2016
December 2015
August 2015
June 2015
May 2015
April 2015
March 2015
February 2015
January 2015
December 2014
October 2014
September 2014
July 2014
June 2014
May 2014
April 2014
February 2014
December 2013
November 2013
October 2013
September 2013
July 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
May 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
December 2006
November 2006
October 2006
September 2006
August 2006
July 2006
June 2006
May 2006
April 2006
March 2006
February 2006
January 2006
December 2005
November 2005
October 2005
September 2005
August 2005
July 2005
June 2005
May 2005
April 2005
March 2005
February 2005
January 2005
December 2004
November 2004
October 2004
September 2004
August 2004
June 2004
May 2004
April 2004
March 2004
February 2004
January 2004
December 2003
November 2003
October 2003
September 2003
August 2003
July 2003
June 2003
May 2003
April 2003
March 2003
February 2003
January 2003
December 2002
November 2002
October 2002
September 2002
August 2002
July 2002
June 2002
May 2002
April 2002
March 2002
February 2002
January 2002
December 2001
November 2001
October 2001
September 2001
August 2001
July 2001
June 2001
May 2001
April 2001
March 2001
February 2001
January 2001
December 2000
November 2000
October 2000
September 2000
August 2000
July 2000
June 2000
May 2000
April 2000
March 2000
February 2000
January 2000
December 1999
November 1999
October 1999
September 1999
August 1999
July 1999
June 1999
May 1999
April 1999
March 1999
February 1999
January 1999
December 1998
November 1998
October 1998
September 1998


JiscMail is a Jisc service.

View our service policies at https://www.jiscmail.ac.uk/policyandsecurity/ and Jisc's privacy policy at https://www.jisc.ac.uk/website/privacy-notice

For help and support help@jisc.ac.uk

Secured by F-Secure Anti-Virus CataList Email List Search Powered by the LISTSERV Email List Manager